Cite
Rech M, Kuhn AR, Lumens J, et al. AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Mol Ther Nucleic Acids. 2018;14:424-437doi: 10.1016/j.omtn.2018.12.010.
Rech, M., Kuhn, A. R., Lumens, J., Carai, P., van Leeuwen, R., Verhesen, W., Verjans, R., Lecomte, J., Liu, Y., Luiken, J. J. F. P., Mohren, R., Cillero-Pastor, B., Heymans, S., Knoops, K., van Bilsen, M., & Schroen, B. (2019). AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Molecular therapy. Nucleic acids, 14424-437. https://doi.org/10.1016/j.omtn.2018.12.010
Rech, Monika, et al. "AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism." Molecular therapy. Nucleic acids vol. 14 (2019): 424-437. doi: https://doi.org/10.1016/j.omtn.2018.12.010
Rech M, Kuhn AR, Lumens J, Carai P, van Leeuwen R, Verhesen W, Verjans R, Lecomte J, Liu Y, Luiken JJFP, Mohren R, Cillero-Pastor B, Heymans S, Knoops K, van Bilsen M, Schroen B. AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism. Mol Ther Nucleic Acids. 2019 Mar 01;14:424-437. doi: 10.1016/j.omtn.2018.12.010. Epub 2018 Dec 22. PMID: 30731323; PMCID: PMC6365487.
Copy
Download .nbib